Form 10-Q Jefferson Capital, Inc. For: Mar 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260514/ANBYH22C8Z2232Z222TO2MZZ6F5SZ2Q2D282
Filed on: May 14, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Football Stars Missing This Summer's Cup Receive an Invitation from Ecuador
- New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple my
- Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
